In this context, the fused enzyme G6PD::6PGL has been proposed as a promising specific target for the search and development of new treatments for parasitic diseases, including malaria, trichomoniasis, and giardiasis. Here, G6PD is linked to Trichomonas vaginitis urogenital infection.